How big is a macropolycyte?
Revisiting Darwinism explains extinction of fetal erythroid progenitors in a leukaemogenic model of a paediatric myeloproliferative neoplasm
Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies
Use of NK cell activity in cure by transplant
Guidelines for the laboratory investigation of heritable disorders of platelet function
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia
Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance
Array-based DNA methylation profiling in acute myeloid leukaemia
Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family
BIOMED-2 PCR assays for IGK gene rearrangements are essential for B-cell clonality analysis in follicular lymphoma
Resveratrol ameliorates TNFα-mediated suppression of erythropoiesis in human CD34+ cells via modulation of NF-κB signalling
Pulmonary function in thalassaemia major and its correlation with body iron stores
Mortality and causes of death in children with sickle cell disease in the Netherlands, before the introduction of neonatal screening
Membrane compartmentalization in Southeast Asian ovalocytosis red blood cells
Lipoproteins, statins and septic haematology patients
Detection of a monoclonal antibody therapy (ofatumumab) by serum protein and immunofixation electrophoresis
High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei
Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population study
Reduced dose chemotherapy for acute promyelocytic leukaemia with adult Down syndrome